Correlation Between Zomedica Pharmaceuticals and SNDL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zomedica Pharmaceuticals and SNDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zomedica Pharmaceuticals and SNDL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zomedica Pharmaceuticals Corp and SNDL Inc, you can compare the effects of market volatilities on Zomedica Pharmaceuticals and SNDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zomedica Pharmaceuticals with a short position of SNDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zomedica Pharmaceuticals and SNDL.

Diversification Opportunities for Zomedica Pharmaceuticals and SNDL

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Zomedica and SNDL is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Zomedica Pharmaceuticals Corp and SNDL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SNDL Inc and Zomedica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zomedica Pharmaceuticals Corp are associated (or correlated) with SNDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SNDL Inc has no effect on the direction of Zomedica Pharmaceuticals i.e., Zomedica Pharmaceuticals and SNDL go up and down completely randomly.

Pair Corralation between Zomedica Pharmaceuticals and SNDL

Considering the 90-day investment horizon Zomedica Pharmaceuticals Corp is expected to under-perform the SNDL. In addition to that, Zomedica Pharmaceuticals is 1.12 times more volatile than SNDL Inc. It trades about 0.0 of its total potential returns per unit of risk. SNDL Inc is currently generating about 0.03 per unit of volatility. If you would invest  153.00  in SNDL Inc on September 14, 2024 and sell it today you would earn a total of  24.50  from holding SNDL Inc or generate 16.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zomedica Pharmaceuticals Corp  vs.  SNDL Inc

 Performance 
       Timeline  
Zomedica Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zomedica Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zomedica Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
SNDL Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SNDL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Zomedica Pharmaceuticals and SNDL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zomedica Pharmaceuticals and SNDL

The main advantage of trading using opposite Zomedica Pharmaceuticals and SNDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zomedica Pharmaceuticals position performs unexpectedly, SNDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SNDL will offset losses from the drop in SNDL's long position.
The idea behind Zomedica Pharmaceuticals Corp and SNDL Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope